In last trading session, Merck & Co Inc (NYSE:MRK) saw 13.72 million shares changing hands with its beta currently measuring 0.40. Company’s recent per share price level of $78.83 trading at -$0.84 or -1.05% at ring of the bell on the day assigns it a market valuation of $197.94B. That closing price of MRK’s stock is at a discount of -69.26% from its 52-week high price of $133.43 and is indicating a premium of 7.0% from its 52-week low price of $73.31. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 17.31 million shares which gives us an average trading volume of 15.86 million if we extend that period to 3-months.
For Merck & Co Inc (MRK), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.88. Splitting up the data highlights that, out of 19 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 19 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Merck & Co Inc (NYSE:MRK) trade information
Upright in the red during last session for losing -1.05%, in the last five days MRK remained trading in the red while hitting it’s week-highest on Tuesday, 06/24/25 when the stock touched $78.83 price level, adding 3.23% to its value on the day. Merck & Co Inc’s shares saw a change of -40.71% in year-to-date performance and have moved -0.58% in past 5-day. Merck & Co Inc (NYSE:MRK) showed a performance of 1.60% in past 30-days. Number of shares sold short was 35.8 million shares which calculate 2.5 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 94 to the stock, which implies a rise of 16.14% to its current value. Analysts have been projecting 82 as a low price target for the stock while placing it at a high target of 106. It follows that stock’s current price would drop -4.02% in reaching the projected high whereas dropping to the targeted low would mean a loss of -4.02% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 12.04% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 16.31% while estimates for its earnings growth in next 5 years are of 11.64%.
MRK Dividends
Merck & Co Inc is more likely to be releasing its next quarterly report on 2025-Apr-24 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt. With an annual yield of 4.06%, the share has a forward dividend of 3.20 which implies that company’s dividend yield remained growing in trailing twelve months while having a 5 year average dividend yield of 2.97%.
Merck & Co Inc (NYSE:MRK)’s Major holders
Insiders are in possession of 0.06% of company’s total shares while institution are holding 80.73 percent of that, with stock having share float percentage of 80.78%. Investors also watch the number of corporate investors in a company very closely, which is 80.73% institutions for Merck & Co Inc that are currently holding shares of the company. VANGUARD GROUP INC is the top institutional holder at MRK for having 244.68 million shares of worth $30.29 billion. And as of 2024-06-30, it was holding 9.6558 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 207.3 million shares on 2024-06-30. The number of shares represents firm’s hold over 8.1806 of outstanding shares, having a total worth of $25.66 billion.
